Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer-Reference-Cited by-同舟云学术

Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer

Published:2021-10 Issue:5 Volume:21 Page:e584-e593
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Joy Anil A.,Vos Larissa J.,Pituskin Edith,Cook Sarah F.,Bies Robert R.,Vlahadamis Ann,King Karen,Basi Sanraj K.,Meza-Junco Judith,Mackey John R.,Stanislaus Avalyn,Damaraju Vijaya L.,Damaraju Sambasivarao,Sawyer Michael B.

Funder

Alberta Cancer Foundation

Alberta Innovates - Health Solutions

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

3. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

4. Cyclophosphamide, epirubicin, and fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by paclitaxel versus doxorubicin and cyclophosphamide followed by paclitaxel in node-positive or high-risk node-negative breast cancer;Burnell;J Clin Oncol,2010

5. Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial;Focan;J Clin Oncol,1993

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel epirubicin-loaded nanoformulations: Advancements in polymeric nanocarriers for efficient targeted cellular and subcellular anticancer drug delivery;Inorganic Chemistry Communications;2023-09

2. A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution;Pharmaceutics;2023-04-12

3. The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers;Cancers;2022-11-21